Refolding and purification of recombinant human interferon-γ expressed as inclusion bodies in Escherichia coli using size exclusion chromatography

被引:20
作者
Guan, YX
Pan, HX
Gao, YG
Yao, SJ [1 ]
Cho, MG
机构
[1] Zhejiang Univ, Dept Chem & Biochem Engn, Hangzhou 310027, Peoples R China
[2] Dongseo Univ, Grad Sch Biotechnol, Adv Sci & Technol Res Ctr, Pusan 617716, South Korea
基金
中国国家自然科学基金;
关键词
size exclusion chromatography (SEC); recombinant human interferon-gamma; protein refolding; purification; inclusion bodies;
D O I
10.1007/BF02932581
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A size exclusion chromatography (SEC) process, in the presence of denaturant in the refolding buffer was developed to refold recombinant human interferon-gamma (rhIFN-gamma) at a high concentration. The rhIFN-gamma was overexpressed in E. coli, resulting in the formation of inactive inclusion bodies (IBs). The IBs were first solubilized in 8 M urea as the denaturant, and then the refolding process performed by decreasing the urea concentration on the SEC column to suppress protein aggregation. The effects of the urea concentration, protein loading mode and column height during the refolding step were investigated. The combination of the buffer-exchange effect of SEC and a moderate urea concentration in the refolding buffer resulted in an efficient route for producing correctly folded rhIFN-gamma, with protein recovery of 67.1% and specific activity up to 1.2 x 10(7) IU/mg.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 24 条
[1]   Considerations of sample application and elution during size-exclusion chromatography-based protein refolding [J].
Batas, B ;
Chaudhuri, JB .
JOURNAL OF CHROMATOGRAPHY A, 1999, 864 (02) :229-236
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Refolding of protein inclusion bodies directly from E-coli homogenate using expanded bed adsorption chromatography [J].
Cho, TH ;
Ahn, SJ ;
Lee, EK .
BIOSEPARATION, 2001, 10 (4-5) :189-196
[4]   Protein refolding for industrial processes [J].
Clark, ED .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :202-207
[5]  
CREIGHTON T. E., 1990, U.S. Patent, Patent No. [4,977,248, 4977248]
[6]  
Cui ZF, 2004, CHINESE J CHEM ENG, V12, P556
[7]  
DU P, 1984, MED INTERFERON, P231
[8]   Refolding and purification of a urokinase plasminogen activator fragment by chromatography [J].
Fahey, EM ;
Chaudhuri, JB ;
Binding, P .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 737 (1-2) :225-235
[9]   On-column refolding of recombinant human interferon-γ with an immobilized chaperone fragment [J].
Gao, YG ;
Guan, YX ;
Yao, SJ ;
Cho, MG .
BIOTECHNOLOGY PROGRESS, 2003, 19 (03) :915-920
[10]   Refolding of lysozyme at high concentration in batch and fed-batch operation [J].
Gao, YG ;
Guan, YX ;
Yao, SJ ;
Cho, MG .
KOREAN JOURNAL OF CHEMICAL ENGINEERING, 2002, 19 (05) :871-875